← Back to Clinical Trials
Recruiting NCT07168590

NCT07168590 Anatomical Axis on X-Ray and Its Relationship With Pain and Kinesiophobia in Knee Osteoarthritis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07168590
Status Recruiting
Phase
Sponsor Selim Sezikli
Condition Knee Osteoarthritis
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-09-08
Primary Completion 2026-09-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-09-08 with a primary completion date of 2026-09-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Knee osteoarthritis is a common joint disease that causes pain, stiffness, and limitations in daily activities, especially in older adults. Changes in the alignment of the lower limb, called the anatomical axis, can increase the mechanical load on the knee joint and may affect pain and mobility. This study aims to investigate the relationship between the anatomical axis measured on knee X-rays and patients' pain levels, functional status, quality of life, and fear of movement (kinesiophobia). This is a single-center, observational, cross-sectional study. Adult patients diagnosed with knee osteoarthritis who have a standard knee X-ray taken within the last 6 months and who volunteer to participate will be included. Pain will be measured with the Visual Analog Scale (VAS), functional status with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), quality of life with the 36-Item Short Form Health Survey (SF-36), and kinesiophobia with the Tampa Scale for Kinesiophobia (TSK). The femoro-tibial angle and joint space width will be measured on X-rays by two independent observers. By examining the relationship between radiographic alignment and clinical findings, this study may provide new insights into the comprehensive evaluation of knee osteoarthritis and help guide treatment planning for patients.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of knee osteoarthritis (clinical and radiographic) * Having an anteroposterior knee X-ray taken within the last 6 months * Voluntary agreement to participate in the study * Cognitive ability sufficient to understand test instructions Exclusion Criteria: * History of knee surgery * Illiteracy (inability to read/write) * Refusal to participate * Presence of orthopedic conditions that prevent walking (e.g., amputation, joint prosthesis)

Contact & Investigator

Central Contact

Selim Sezikli, MD

✉ selimsezikli@hotmail.com

📞 +90 506 510 18 33

Principal Investigator

Selim Sezikli, MD

PRINCIPAL INVESTIGATOR

Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

Frequently Asked Questions

Who can join the NCT07168590 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07168590 currently recruiting?

Yes, NCT07168590 is actively recruiting participants. Contact the research team at selimsezikli@hotmail.com for enrollment information.

Where is the NCT07168590 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07168590 clinical trial?

NCT07168590 is sponsored by Selim Sezikli. The principal investigator is Selim Sezikli, MD at Istanbul Physical Medicine and Rehabilitation Training and Research Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology